학술논문
Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis
Document Type
Article
Author
Source
In: Inflammatory Bowel Diseases . (Inflammatory Bowel Diseases, November 2010, 16(11):1947-1956)
Subject
Language
English
ISSN
10780998
15364844
15364844